​
Avaz Logo
MOJ PROFILUREDI PROFILODJAVI SEOBRIŠI PROFIL
# biontech en
EU drugs agency authorizes BioNTech vaccines for children age 5-12

CORONAVIRUS OUTBREAK

25.11.2021

EU drugs agency authorizes BioNTech vaccines for children age 5-12

Pfizer, BioNTech say COVID-19 booster shot's efficacy nearly 96%

PANDEMIC

21.10.2021

Pfizer, BioNTech say COVID-19 booster shot's efficacy nearly 96%

BioNTech begins Phase 2 trial of mRNA-based vaccine against cancer

WORLD NEWS

1.10.2021

BioNTech begins Phase 2 trial of mRNA-based vaccine against cancer

Pfizer, BioNTech post positive vaccine results in children age 5-11

CORONAVIRUS OUTBREAK

20.9.2021

Pfizer, BioNTech post positive vaccine results in children age 5-11

Covid jab maker BioNTech to build SE Asia manufacturing site

SINGAPORE

10.5.2021

Covid jab maker BioNTech to build SE Asia manufacturing site

Pfizer/BioNTech to supply vaccines for Olympic athletes

SPORTS

6.5.2021

Pfizer/BioNTech to supply vaccines for Olympic athletes

BioNTech nearing request for approval of longer-lasting version of COVID vaccine

PHARMACEUTICALS

4.5.2021

BioNTech nearing request for approval of longer-lasting version of COVID vaccine

EU drug agency starts Covid jab evaluation for 12 to 15-year olds

PFIZER / BIONTECH

3.5.2021

EU drug agency starts Covid jab evaluation for 12 to 15-year olds

BioNTech eyes Covid vaccine for 12-15 year olds from June in EU

CORONAVIRUS OUTBREAK

29.4.2021

BioNTech eyes Covid vaccine for 12-15 year olds from June in EU

BioNTech co-founder 'confident' vaccine works against Indian variant

CORONAVIRUS OUTBREAK

28.4.2021

BioNTech co-founder 'confident' vaccine works against Indian variant

Pfizer/BioNTech say vaccine effective against S.Africa variant

PANDEMIC

1.4.2021

Pfizer/BioNTech say vaccine effective against S.Africa variant

EU to purchase 200M extra doses of BioNTech vaccine

CORONAVIRUS

17.2.2021

EU to purchase 200M extra doses of BioNTech vaccine

Pfizer sees $15 billion in 2021 sales from COVID-19 vaccine

ECONOMY

2.2.2021

Pfizer sees $15 billion in 2021 sales from COVID-19 vaccine

Sanofi to help produce 100 million Pfizer/BioNTech vaccine doses

CORONAVIRUS

28.1.2021

Sanofi to help produce 100 million Pfizer/BioNTech vaccine doses

Pfizer/BioNTech say vaccine effective against UK, SAfrica virus mutations

CORONAVIRUS

28.1.2021

Pfizer/BioNTech say vaccine effective against UK, SAfrica virus mutations

PrethodnaSljedeća

# biontech en

EU drugs agency authorizes BioNTech vaccines for children age 5-12

CORONAVIRUS OUTBREAK

EU drugs agency authorizes BioNTech vaccines for children age 5-12

25.11.2021

Pfizer, BioNTech say COVID-19 booster shot's efficacy nearly 96%

PANDEMIC

Pfizer, BioNTech say COVID-19 booster shot's efficacy nearly 96%

21.10.2021

BioNTech begins Phase 2 trial of mRNA-based vaccine against cancer

WORLD NEWS

BioNTech begins Phase 2 trial of mRNA-based vaccine against cancer

1.10.2021

Pfizer, BioNTech post positive vaccine results in children age 5-11

CORONAVIRUS OUTBREAK

Pfizer, BioNTech post positive vaccine results in children age 5-11

20.9.2021

Covid jab maker BioNTech to build SE Asia manufacturing site

SINGAPORE

Covid jab maker BioNTech to build SE Asia manufacturing site

10.5.2021

Pfizer/BioNTech to supply vaccines for Olympic athletes

SPORTS

Pfizer/BioNTech to supply vaccines for Olympic athletes

6.5.2021

BioNTech nearing request for approval of longer-lasting version of COVID vaccine

PHARMACEUTICALS

BioNTech nearing request for approval of longer-lasting version of COVID vaccine

4.5.2021

EU drug agency starts Covid jab evaluation for 12 to 15-year olds

PFIZER / BIONTECH

EU drug agency starts Covid jab evaluation for 12 to 15-year olds

3.5.2021

BioNTech eyes Covid vaccine for 12-15 year olds from June in EU

CORONAVIRUS OUTBREAK

BioNTech eyes Covid vaccine for 12-15 year olds from June in EU

29.4.2021

BioNTech co-founder 'confident' vaccine works against Indian variant

CORONAVIRUS OUTBREAK

BioNTech co-founder 'confident' vaccine works against Indian variant

28.4.2021

Pfizer/BioNTech say vaccine effective against S.Africa variant

PANDEMIC

Pfizer/BioNTech say vaccine effective against S.Africa variant

1.4.2021

EU to purchase 200M extra doses of BioNTech vaccine

CORONAVIRUS

EU to purchase 200M extra doses of BioNTech vaccine

17.2.2021

Pfizer sees $15 billion in 2021 sales from COVID-19 vaccine

ECONOMY

Pfizer sees $15 billion in 2021 sales from COVID-19 vaccine

2.2.2021

Sanofi to help produce 100 million Pfizer/BioNTech vaccine doses

CORONAVIRUS

Sanofi to help produce 100 million Pfizer/BioNTech vaccine doses

28.1.2021

Pfizer/BioNTech say vaccine effective against UK, SAfrica virus mutations

CORONAVIRUS

Pfizer/BioNTech say vaccine effective against UK, SAfrica virus mutations

28.1.2021

Besplatno se pretplatite na naš newsletter
Primajte najvažnije i najpopularnije vijesti sa portala Avaz.ba
Povremeno možete dobiti promotivni materijal
PrethodnaSljedeća
footer:avaz-logo
Facebook
Twitter
Instagram
YouTube
WhatsApp
Viber
LinkedIn
Impressum
Oglašavanje
Uslovi korištenja
Politika privatnosti
Kontakt
Vlasnik autorskih prava © avaz-roto press d.o.o.
ISSN 1840-3522.
Zabranjeno preuzimanje sadržaja bez dozvole izdavača.